3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Lung Neoplasms
22
Carcinoma, Non-Small-Cell Lung
15
Ovarian Neoplasms
12
Fallopian Tube Neoplasms
11
Carcinoma, Hepatocellular
9
Colorectal Neoplasms
8
Urinary Bladder Neoplasms
7
Pancreatic Neoplasms
7
Melanoma
6
Lymphoma, Large B-Cell, Diffuse
6
Mycosis Fungoides
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Carcinoma, Renal Cell
5
Squamous Cell Carcinoma of Head and Neck
4
Neoplasm Metastasis
4
Lymphoma, T-Cell, Cutaneous
4
Glioblastoma
4
Colonic Neoplasms
4
Breast Neoplasms
4
Triple Negative Breast Neoplasms
3
Thyroid Neoplasms
3
Sezary Syndrome
3
Rectal Neoplasms
3
Nasopharyngeal Carcinoma
3
Multiple Myeloma
3
Mouth Neoplasms
3
Lymphoma, T-Cell
3
Lymphoma, B-Cell
3
Endometrial Neoplasms
3
Cholangiocarcinoma
3
Interventions
Cyclophosphamide
12
Specimen Handling
9
cabozantinib
8
X-Rays
8
Magnetic Resonance Spectroscopy
8
fludarabine
7
Phantoms, Imaging
7
Biopsy
7
Temozolomide
6
Gemcitabine
5
regorafenib
4
pembrolizumab
4
Vincristine
4
Nuclear Medicine Department, Hospital
4
Nivolumab
4
Methotrexate
4
Doxorubicin
4
olaparib
3
irinotecan sucrosofate
3
fludarabine phosphate
3
dinutuximab
3
Zoledronic Acid
3
Surveys and Questionnaires
3
Irinotecan
3
Ifosfamide
3
Cisplatin
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Osteosarcoma
×
Disulfides
×
1 year
×
Clear all
NCT04668300
2026-04-15
DOSa
M.D. Anderson Cancer Center
Phase 2
Active not recruiting
75 enrolled